HK1140698A1 - Beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis 14- - Google Patents
Beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis 14-Info
- Publication number
- HK1140698A1 HK1140698A1 HK10107264.2A HK10107264A HK1140698A1 HK 1140698 A1 HK1140698 A1 HK 1140698A1 HK 10107264 A HK10107264 A HK 10107264A HK 1140698 A1 HK1140698 A1 HK 1140698A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- endoartherectomy
- 14beta
- angioplastic
- restenosis
- beta
- Prior art date
Links
- QZLYKIGBANMMBK-CCZRDMDKSA-N (8s,9s,10s,13s,14r)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene Chemical class C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@H]1CCC[C@@]1(C)CC2 QZLYKIGBANMMBK-CCZRDMDKSA-N 0.000 title 1
- 206010016654 Fibrosis Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000004761 fibrosis Effects 0.000 title 1
- 210000000056 organ Anatomy 0.000 title 1
- 208000037803 restenosis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07109779 | 2007-06-07 | ||
PCT/EP2008/056928 WO2008148812A1 (en) | 2007-06-07 | 2008-06-04 | 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1140698A1 true HK1140698A1 (en) | 2010-10-22 |
Family
ID=38662675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10107264.2A HK1140698A1 (en) | 2007-06-07 | 2010-07-29 | Beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis 14- |
Country Status (19)
Country | Link |
---|---|
US (1) | US20100303896A1 (es) |
EP (1) | EP2160190B1 (es) |
JP (1) | JP5579058B2 (es) |
KR (1) | KR101530019B1 (es) |
CN (1) | CN101720224B (es) |
AU (1) | AU2008258521B2 (es) |
BR (1) | BRPI0812775B8 (es) |
CA (1) | CA2688079C (es) |
DK (1) | DK2160190T3 (es) |
ES (1) | ES2556731T3 (es) |
HK (1) | HK1140698A1 (es) |
HR (1) | HRP20151233T1 (es) |
HU (1) | HUE025599T2 (es) |
MX (1) | MX2009012917A (es) |
PL (1) | PL2160190T3 (es) |
PT (1) | PT2160190E (es) |
RS (1) | RS54459B1 (es) |
SI (1) | SI2160190T1 (es) |
WO (1) | WO2008148812A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010227644B2 (en) * | 2009-03-23 | 2016-05-19 | Cvie Therapeutics Limited | 5-beta, 14-beta-androstane derivatives useful for the treatment of proteinuria, glomerulosclerosis and renal failure |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW226375B (es) * | 1991-10-24 | 1994-07-11 | American Home Prod | |
EP0625902A1 (en) * | 1992-02-14 | 1994-11-30 | Warner-Lambert Company | Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist |
DE4227616C2 (de) * | 1992-08-20 | 1995-04-13 | Sigma Tau Ind Farmaceuti | 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen |
DE4232638C2 (de) * | 1992-09-29 | 1994-11-17 | Sigma Tau Ind Farmaceuti | 17-Phenyl-5beta-14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
ES2126061T3 (es) * | 1993-03-24 | 1999-03-16 | American Home Prod | Piridopirimidinas substituidas como antihipertensores. |
WO2004089416A2 (en) * | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent |
EP1812010A2 (en) * | 2004-10-18 | 2007-08-01 | BTG International Limited | Use of na+/ k+-atpase inhibitors and antagonists thereof |
-
2008
- 2008-06-04 RS RS20150845A patent/RS54459B1/en unknown
- 2008-06-04 WO PCT/EP2008/056928 patent/WO2008148812A1/en active Application Filing
- 2008-06-04 HU HUE08760508A patent/HUE025599T2/en unknown
- 2008-06-04 KR KR1020097024493A patent/KR101530019B1/ko active IP Right Grant
- 2008-06-04 DK DK08760508.5T patent/DK2160190T3/en active
- 2008-06-04 ES ES08760508.5T patent/ES2556731T3/es active Active
- 2008-06-04 US US12/602,827 patent/US20100303896A1/en not_active Abandoned
- 2008-06-04 AU AU2008258521A patent/AU2008258521B2/en not_active Ceased
- 2008-06-04 SI SI200831539T patent/SI2160190T1/sl unknown
- 2008-06-04 JP JP2010510789A patent/JP5579058B2/ja not_active Expired - Fee Related
- 2008-06-04 EP EP08760508.5A patent/EP2160190B1/en active Active
- 2008-06-04 BR BRPI0812775A patent/BRPI0812775B8/pt not_active IP Right Cessation
- 2008-06-04 CA CA2688079A patent/CA2688079C/en active Active
- 2008-06-04 MX MX2009012917A patent/MX2009012917A/es active IP Right Grant
- 2008-06-04 PL PL08760508T patent/PL2160190T3/pl unknown
- 2008-06-04 PT PT87605085T patent/PT2160190E/pt unknown
- 2008-06-04 CN CN200880019175.XA patent/CN101720224B/zh active Active
-
2010
- 2010-07-29 HK HK10107264.2A patent/HK1140698A1/xx not_active IP Right Cessation
-
2015
- 2015-11-16 HR HRP20151233TT patent/HRP20151233T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
CA2688079C (en) | 2016-05-03 |
WO2008148812A1 (en) | 2008-12-11 |
RS54459B1 (en) | 2016-06-30 |
KR20100022021A (ko) | 2010-02-26 |
BRPI0812775A2 (pt) | 2014-12-02 |
CA2688079A1 (en) | 2008-12-11 |
AU2008258521A1 (en) | 2008-12-11 |
JP2010529082A (ja) | 2010-08-26 |
EP2160190A1 (en) | 2010-03-10 |
KR101530019B1 (ko) | 2015-06-18 |
BRPI0812775B1 (pt) | 2020-02-04 |
CN101720224B (zh) | 2014-03-26 |
PL2160190T3 (pl) | 2016-03-31 |
JP5579058B2 (ja) | 2014-08-27 |
DK2160190T3 (en) | 2016-01-11 |
ES2556731T3 (es) | 2016-01-19 |
CN101720224A (zh) | 2010-06-02 |
PT2160190E (pt) | 2016-01-27 |
MX2009012917A (es) | 2010-01-14 |
AU2008258521B2 (en) | 2013-03-28 |
US20100303896A1 (en) | 2010-12-02 |
HRP20151233T1 (hr) | 2015-12-18 |
HUE025599T2 (en) | 2016-05-30 |
EP2160190B1 (en) | 2015-11-04 |
SI2160190T1 (sl) | 2015-12-31 |
BRPI0812775B8 (pt) | 2021-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL216967B (en) | The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases | |
HK1154382A1 (en) | Triazole derivatives useful for the treatment of diseases | |
IL193230A (en) | Use of benzoxoborol derivatives in the preparation of drugs for the treatment of inflammatory diseases | |
HK1153926A1 (en) | Purin derivatives for use in the treatment of fab-related diseases fab- | |
IL187816A0 (en) | Substituted phenylphosphates as mutual prodrugs of steroids and ??-agonists for the treatment of pulmonary inflammation and bronchoconstriction | |
HK1170485A1 (zh) | -噻唑烷- -酮衍生物及其在癌症治療中的用途 | |
IL200549A0 (en) | 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease | |
SI2148667T1 (sl) | Uporaba derivatov cikloheksanheksola pri zdravljenju okularnih bolezni | |
EP2217238A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF DISEASES RELATED TO PROTEINURIA | |
IL194880A (en) | Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them | |
FI20095600A (fi) | Koostumus ihosairauksien hoitoa varten | |
IL210290A0 (en) | Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis | |
ZA201108106B (en) | Use of phthalimide derivatives in the treatment of diseases | |
HK1158954A1 (en) | 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases | |
IL206464A0 (en) | Pharmaceutical composition, use of 2-imminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases | |
HK1140698A1 (en) | Beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis 14- | |
EP2157089A4 (en) | THERAPEUTIC USES OF IMIDAZOL-5-CARBOXYLIC ACID DERIVATIVES | |
HK1144247A1 (en) | Use of osteoblasts in the treatment of inflammatory rheumatic diseases | |
IL194261A0 (en) | S-alkylisothiouronium derivatives for the treatment of inflammatory diseases | |
IL202502A0 (en) | Agents for the treatment of inflammatory diseases and methods of using same | |
ZA200605368B (en) | Gallic acid derivative and process of preparing the same | |
IL178853A0 (en) | Tar composition for the treatment of skin diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230604 |